MedTrace Logo

Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation

NCT01206309 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 911

Last updated 2016-10-07

No results posted yet for this study

Summary

The purpose of this research study is to better understand the onset and course of graft versus host disease (GVHD)and other immune-mediated disorders after stem cell transplant.

Conditions

  • Graft vs Host Disease
  • Cutaneous Sclerosis
  • Bronchiolitis Obliterans

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Fred Hutchinson Cancer Center

    lead OTHER

Principal Investigators

  • Stephanie Lee, MD, MPH · Fred Hutchinson Cancer Center

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2016-10-31
Completion
2016-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01206309 on ClinicalTrials.gov